Search results for "Heart Failure"
Appropriate antibiotics for CAP linked to lower 1-year cardiovascular death risk in older inpatients
A Canadian study of nearly 2,000 patients older than age 65 years who were hospitalized with community-acquired pneumonia (CAP) found that use of guideline-concordant antibiotic therapy was associated with a 47% reduction in cardiovascular death at one year after infection.
https://acphospitalist.acponline.org/archives/2023/01/11/appropriate-antibiotics-for-CAP-linked-to-lower-1-year-cardiovascular-death-risk-in-older-inpatients.htm
11 Jan 2023
Social drivers of health associated with care, behaviors after stroke hospitalization
One-third of stroke patients didn't achieve an adequate transition of care (based on adherence to medication, follow-up visits, exercise recommendations, diet modification, and cessation of smoking or drug use), according to a study in Florida.
https://acphospitalist.acponline.org/archives/2023/01/04/social-drivers-of-health-associated-with-care-behaviors-after-stroke-hospitalization.htm
4 Jan 2023
The year's top headlines
We collected the top five most read ACP Hospitalist articles of 2022 and identified some themes.
https://acphospitalist.acponline.org/archives/2022/12/28/the-years-top-headlines.htm
28 Dec 2022
Persistent depressive symptoms linked to death, readmission after HF hospitalization
Heart failure (HF) patients with persistent depressive symptoms at one month after discharge had more than double the risk of cardiovascular death within a year as those without depression, a Chinese study found.
https://acphospitalist.acponline.org/archives/2022/12/21/persistent-depressive-symptoms-linked-to-death-readmission-after-hf-hospitalization.htm
21 Dec 2022
AHA statement reviews efficacy, safety of CAM therapies in patients with heart failure
Potentially beneficial complementary and alternative medicine (CAM) therapies included omega-3 polyunsaturated fatty acids, coenzyme Q10, D-ribose, and L-carnitine, the American Heart Association (AHA) said.
https://acphospitalist.acponline.org/archives/2022/12/14/aha-statement-reviews-efficacy-safety-of-cam-therapies-in-patients-with-heart-failure.htm
14 Dec 2022
Do-not-attempt-resuscitation order rates compared for heart failure, other hospital conditions
A retrospective study in California found low overall rates of do-not-attempt-resuscitation orders in patients hospitalized for heart failure, pneumonia, acute myocardial infarction, or chronic obstructive pulmonary disease, with some variation by race.
https://acphospitalist.acponline.org/archives/2022/11/23/free/do-not-attempt-resuscitation-order-rates-compared-for-heart-failure-other-hospital-conditions.htm
23 Nov 2022
High-intensity medical therapy at HF discharge reduced readmissions, death
Researchers stopped the STRONG-HF randomized trial early due to greater than expected differences in outcomes between patients who received rapid up-titration of guideline-directed medical therapy under strict follow-up and those who received usual care.
https://acphospitalist.acponline.org/archives/2022/11/16/high-intensity-medical-therapy-at-hf-discharge-reduced-readmissions-death.htm
16 Nov 2022
Algorithm for HF risk stratification in the ED associated with better 30-day outcomes
A trial in Ontario used a point-of-care algorithm to determine whether patients seen in the ED for acute heart failure (HF) should be discharged directly from the ED or after up to three days of observation, followed by transitional care in a heart failure clinic, or be admitted for inpatient care.
https://acphospitalist.acponline.org/archives/2022/11/16/algorithm-for-hf-risk-stratification-in-the-ed-associated-with-better-30-day-outcomes.htm
16 Nov 2022
An atypical presentation of microscopic polyangiitis
A patient was admitted after outpatient labs indicated acute worsening of kidney disease and anemia.
https://acphospitalist.acponline.org/archives/2022/10/26/free/brief-case-an-atypical-presentation-of-microscopic-polyangiitis.htm
26 Oct 2022
Acetazolamide improved decongestion in acute decompensated heart failure
A randomized trial found that the drug, already approved for other indications, achieved successful decongestion within three days in 42.2% of acute decompensated heart failure patients, compared to 30.5% of those on placebo.
https://acphospitalist.acponline.org/archives/2022/08/31/acetazolamide-improved-decongestion-in-acute-decompensated-heart-failure.htm
31 Aug 2022